# Mondiale vergelijking van heropnamepercentages bij hartfalen

*geplaatst 2023-08-01 · Hartfalen · Journal of the American College of Cardiology · doi 10.1016/j.jacc.2023.05.040 · https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/*

Internationale vergelijking toonde aanzienlijke variatie in hartfalen-heropnamepercentages wereldwijd. Lagere percentages in sommige landen weerspiegelen betere transitiezorg en nazorgprogramma's, wat best practices identificeert.

## English: Global Comparison of Readmission Rates for Patients With Heart Failure.

This international comparison revealed substantial variation in heart failure readmission rates across countries, identifying healthcare system factors that may explain differences and offering benchmarks for quality improvement.

## Abstract (original, from the publication)

BACKGROUND: Heart failure (HF) readmission rates are low in some jurisdictions. However, international comparisons are lacking and could serve as a foundation for identifying regional patient management strategies that could be shared to improve outcomes. OBJECTIVES: This study sought to summarize 30-day and 1-year all-cause readmission and mortality rates of hospitalized HF patients across countries and to explore potential differences in rates globally. METHODS: We performed a systematic review and meta-analysis using MEDLINE, Embase, and CENTRAL for observational reports on hospitalized adult HF patients at risk for readmission or mortality published between January 2010 and March 2021. We conducted a meta-analysis of proportions using a random-effects model, and sources of heterogeneity were evaluated with meta-regression. RESULTS: In total, 24 papers reporting on 30-day and 23 papers on 1-year readmission were included. Of the 1.5 million individuals at risk, 13.2% (95% CI: 10.5%-16.1%) were readmitted within 30 days and 35.7% (95% CI: 27.1%-44.9%) within 1 year. A total of 33 papers reported on 30-day and 45 papers on 1-year mortality. Of the 1.5 million individuals hospitalized for HF, 7.6% (95% CI: 6.1%-9.3%) died within 30 days and 23.3% (95% CI: 20.8%-25.9%) died within 1 year. Substantial variation in risk across countries was unexplained by countries' gross domestic product, proportion of gross domestic product spent on health care, and Gini coefficient. CONCLUSIONS: Globally, hospitalized HF patients exhibit high rates of readmission and mortality, and the variability in readmission rates was not explained by health care expenditure, risk of mortality, or comorbidities.

Auteurs: Farid Foroutan, Daniel G Rayner, Heather J Ross, Tamara Ehler, Ananya Srivastava, Sheojung Shin, Abdullah Malik, Harsukh Benipal, Clarissa Yu, Tsz Hin Alexander Lau, Joshua G Lee, Rodolfo Rocha, Peter C Austin, Daniel Levy, Jennifer E Ho, John J V McMurray, Faiez Zannad, George Tomlinson, John A Spertus, Douglas S Lee

---
Bron: Journal of the American College of Cardiology, https://doi.org/10.1016/j.jacc.2023.05.040. Bijgewerkt 2026-07-03T13:29:34Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.